Erudio Healtherudio.com
Clinical trial · no report yet · Phase 2
CAREMM-001
A Study of VRd-based Regimen Followed by BCMA CAR-T Therapy in Transplant-Ineligible Patients With New-diagnosed Multiple Myeloma
- NCT05860036 ↗
- Active, not recruiting
- Institute of Hematology & Blood Diseases Hospital, China
- Focused
We haven't built an HCP commentary report on CAREMM-001 (anti-BCMA CAR-T and VRd in Multiple Myeloma) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on CAREMM-001 so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Channel | Indexed | |
|---|---|---|
| X threads | 7 | |
| YouTube | 1 |
The trial
ClinicalTrials.gov- Official title
- Safety and Efficiency of VRd-based Regimen Followed by BCMA CAR-T for New-diagnosed Transplant-ineligible Multiple Myeloma Patients: a Prospective, Single-arm, Single-center, Phase II Study.
- Phase
- Phase 2
- Status
- Active, not recruiting
- Conditions
- Multiple Myeloma
- Interventions
- anti-BCMA CAR-T; VRd
- Arms
- VRd-based regimen Combined With BCMA CART · Experimental
- Enrollment
- 40 (estimated)
- Primary outcomes
- Safety and Tolerability
- MRD-negative rate
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Start
- Apr 4, 2023
- Primary completion
- Jun 1, 2025
- Results posted
- No
- Registry record
- NCT05860036 · updated Aug 3, 2025
Publications
linked from the registry- Yan W, Du C, Lv R, Zou H, Zhang S, Yu T, Yan Y, Zhang Y, Peng S, Wang T, Deng S, Huang W, Yi S, Zou D, Cheng T, Wang J, Chang AH, Qiu L, An G. Phase II Study of BCMA Chimeric Antigen Receptor T-Cell Therapy in Patients With Newly Diagnosed Multiple Myeloma Ineligible for or Not Proceeding to Autologous Stem-Cell Transplantation (CAREMM-001). J Clin Oncol. 2026 Apr 10;44(11):992-1002. doi: 10.1200/JCO-25-01969. Epub 2026 Feb 27. PubMed 41759038